Clinical Trials Directory

Trials / Unknown

UnknownNCT02004808

Neutrophil Extracellular Traps and Sickle Cell Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
15 (estimated)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
All
Age
1 Month – 18 Years
Healthy volunteers
Not accepted

Summary

NETs formation in vaso-occlusive events in sickle cell disease and the role of hydroxyurea treatment.The study hypothesis is that NETs formation by neutrophils has a role in the induction of vaso occlusive disease in blood vessels. It is possible that high leukocyte count in children with sickle cell anemia is a bad prognostic sign due to NETs formation supporting occlusion of peripheral and central blood vessels.Hydroxyurea treatment might prevent vaso occlusive syndrome not only by increasing HbF but also by decreasing neutrophil count and inhibiting NETs formation.

Conditions

Timeline

Start date
2014-02-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2013-12-09
Last updated
2013-12-09

Source: ClinicalTrials.gov record NCT02004808. Inclusion in this directory is not an endorsement.